Glimiscore Mv2 Tab

Composition

Glimepiride 2 mg + Metformin hydrochloride (modified/extended release) 500 mg + Voglibose 0.2 mg

Uses of Glimiscore Mv2 Tab

Type 2 diabetes mellitus in adults when diet and exercise alone are not enough; helps control post-meal and fasting blood glucose in patients requiring triple therapy.

• •Controls fasting and post-meal blood sugar
• •Improves overall glycaemic control (HbA1c)
• •Reduces postprandial glucose spikes
• •May reduce insulin resistance
• •Convenient triple-combination therapy

How it works

Glimepiride increases insulin release from the pancreas and improves insulin sensitivity. Metformin reduces glucose production in the liver and improves peripheral glucose uptake. Voglibose slows carbohydrate digestion and absorption in the gut, reducing post-meal blood sugar spikes.

Directions for use

Oral tablet. Take exactly as prescribed, usually once daily with/after a main meal (often breakfast) to reduce stomach upset and risk of low sugar; swallow whole (do not crush/chew if modified-release). Monitor blood glucose regularly.

Side effects

Common side effects of Glimiscore Mv2 Tab may include:

• •Hypoglycaemia
• •nausea
• •vomiting
• •diarrhoea